General advice

  • Correct the correctable (for example renal function, hypercalcaemia, hyponatraemia, hyperglycaemia, constipation, symptomatic ascites, cerebral oedema/raised intracranial pressure, review medicines).
  • Consider non-pharmacological measures (refer to non-pharmacological management below).
  • Choose an anti-emetic appropriate to a likely identified cause.
  • A combination of anti-emetics may be appropriate.
  • A broad spectrum anti-emetic may be indicated if multiple concurrent factors are present.
  • Adjuvant corticosteroid and/or benzodiazepine may be combined with the prescribed anti-emetic drug(s).
  • Try to avoid the concurrent prescribing of prokinetics (for example QTmetoclopramide) and anticholinergics (for example cyclizine) medication. The anticholinergics will diminish the prokinetic effect.
  • Consider the route of administration of medication as:
    • the oral route may not provide adequate absorption or be available as a result of nausea (which inhibits gastric emptying) or vomiting
    • buccal or sublingual medication administration may be helpful but may trigger symptoms of nausea or vomiting in susceptible individuals
    • the parenteral route may reduce tablet burden which may be a contributing factor to nausea.
  • Anti-dopaminergics should be avoided in patients with Parkinson’s disease.

 

Non-pharmacological management

Non-pharmacological measures are important and should be considered alongside the prescribing of appropriate anti-emetics. Measures include:

  • Regular mouth care (refer to Mouth care guideline)
  • Regularising bowel habit - constipation may be a relatively common cause of nausea
  • Regular small palatable portions rather than large meals
  • Avoid food preparation and cooking smells
  • A calm and reassuring environment
  • Acupressure bands (for example Seaband®)
  • Acupuncture
  • Psychological approaches.

 

Pharmacological management

Almost all causes of nausea and vomiting can be placed in the following categories, and managed using a specific drug or class of drugs.

Tables are best viewed in landscape mode on mobile devices

Causes

Drug class

Clinical toxicity (including drug induced) or metabolic/biochemical upset (refer to flowchart)

Dopamine receptor antagonist (for example metoclopramide, QThaloperidol or QTlevomepromazine 

Motility disorders (including drug-induced and paraneoplastic gastroparesis)

Prokinetic (for example metoclopramide - caution in use of prolonged higher doses, monitor for extrapyramidal side effects or QTdomperidone)

Intracranial disorders, for example, vestibular dysfunction, motion disorders

Anticholinergic or antihistamine (cyclizine or hyoscine hydrobromide), corticosteroid, QTlevomepromazine or QTprochlorperazine.

Raised Intracranial Pressure

Corticosteroids e.g. dexamethasone 

 

Causes

Drug class

Oral/pharyngeal/oesophageal irritation

Anticholinergic or antihistamine (cyclizine or hyoscine hydrobromide), or QTlevomepromazine.

Multifactorial/unknown/refractory 

Use appropriate anti-emetics for known causes; or broad spectrum anti-emetic QTlevomepromazine.

Higher centres (pain/fear/anxiety)

Optimise pain control treat anxiety.

Chemotherapy and/or radiotherapy-induced nausea and vomiting

Refer to local guidelines.